Hans C. Hasselbalch

Roskilde, 4000, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 229 publications

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

Journal: Cancers
Published: July 10, 2026

Response to " Are statins interferons best friend? Mechanistic insights".

Response to " Are statins interferons best friend? Mechanistic insights".

Journal: Blood advances
Published: June 17, 2026

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Mathematical modeling of JAK2V617F clonal expansion in a general population cohort.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 17, 2026

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm.

Platelet Counts During Pregnancy as Predictor of Subsequent Myeloproliferative Neoplasm.

Journal: European journal of haematology
Published: April 28, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences
Published: January 22, 2026

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Hierarchical mathematical modelling of patients with myeloproliferative neoplasms captures interferon-α treatment responses and allows for personalised and population predictions.

Journal: Mathematical biosciences
Published: January 22, 2026

Metformin: interferon's new dancing partner?

Metformin: interferon's new dancing partner?

Journal: Haematologica
Published: January 22, 2026

Metformin: interferon's new dancing partner?

Metformin: interferon's new dancing partner?

Journal: Haematologica
Published: January 22, 2026

C282Y Homozygosity Increases Erythrocyte Turnover and Decreases HbA1c-A Population-Based Study.

C282Y Homozygosity Increases Erythrocyte Turnover and Decreases HbA1c-A Population-Based Study.

Journal: International journal of molecular sciences
Published: January 13, 2026

Prime Time for The Use of Statins in MPNs: From Comorbidity Drugs to Disease-Modifying Partners.

Prime Time for The Use of Statins in MPNs: From Comorbidity Drugs to Disease-Modifying Partners.

Journal: Blood advances
Published: January 07, 2026

Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Journal: Blood advances
Published: January 07, 2026

Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 Inflammasome.

Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 Inflammasome.

Journal: Thrombosis and haemostasis
Published: December 23, 2025
Showing 1-12 of 229

Last Updated: 09/26/2026